High occurrence of antihistamine resistance in patients with recurrent idiopathic angioedema

  • Zonne L.M. Hofman
  • , Nikki Van West
  • , C. Erik Hack
  • , André C. Knulst
  • , Coen Maas
  • , Heike Röckmann*
  • *Corresponding author for this work

Research output: Contribution to journalLetterAcademicpeer-review

3 Downloads (Pure)

Abstract

Antihistamines are the most prescribed therapy in recurrent idiopathic angioedema, yet little is known about their efficacy. Herein, we report on clinical improvement with antihistamine therapy in 120 patients evaluating angioedema attack frequency. A high incidence (36%) of antihistamine refractory cases was observed. Forty percent of patients on antihistamine prophylaxis suffered from 1 or more angioedema attacks per month. Our findings stress the need for additional treatment options for recurrent idiopathic angioedema.

Original languageEnglish
Article number35
Number of pages5
JournalClinical and Translational Allergy
Volume9
Issue number1
DOIs
Publication statusPublished - 12 Jul 2019

Keywords

  • Angioedema
  • Antihistamines
  • Idiopathic angioedema
  • Omalizumab

Fingerprint

Dive into the research topics of 'High occurrence of antihistamine resistance in patients with recurrent idiopathic angioedema'. Together they form a unique fingerprint.

Cite this